Back to Annual Meeting
Back to Annual Meeting
|
Back to Annual Meeting
|
|
Back to Annual Meeting
|
APHA Scientific Session and Event Listing |
5091.0: Wednesday, November 08, 2006: 10:30 AM-12:00 PM | |||
Oral | |||
| |||
| Avian influenza in its highly pathogenic form has the potential to cause a contagious disease of immense proportions. In addition, the World Bank has estimated that a human pandemic would have an economic cost of $800 billion. The world is watching the global march of this lethal infection in birds cross the planet and has the potential to arrive in the United States. To date, over a million birds have died or been culled. It has also caused illness in over 200 people resulting in the death of over 50% from direct bird to human transmission. Should it mutate to a form that is highly transmissible between people, and remain highly lethal, a serious pandemic is possible. No human vaccine to combat the spread of this current strain is currently available for general use and a specific vaccine against an emerging pandemic strain will take 6 months to produce. This presentation will discuss non-pharmacologic options of disease control, ethical principles to consider in pandemic preparedness and actions needed to effectively engage communities in the response. | |||
| Learning Objectives: At the conclusion of this session participants will be able to: Describe four non-pharmacologic measures of disease control. Understand important ethical principles to consider in pandemic planning and response. Reiterate actions communities can do to prepare for pandemic influenza. | |||
| Walter Tsou, MD, MPH | |||
From SARS and bioterrorism to pandemic flu, new tools and old medicine: Non-pharmaceutical interventions as a way to protect ourselves against contagious disease ![[ Recorded presentation ]](/static/img/filetypes/16x16/wrf.gif){kind=small} David Heyman | |||
| Ethical issues with pandemic flu Robert J. Levine, MD | |||
| Community engagement Donna L. Richter, EdD, FAAHB | |||
| See individual abstracts for presenting author's disclosure statement and author's information. | |||
| Organized by: | APHA-Special Sessions | ||
The 134th Annual Meeting & Exposition (November 4-8, 2006) of APHA